The Effect of withdrawing dutasteride on patients with benign prostatic hyperplasia

The Effect of withdrawing dutasteride on patients with benign prostatic hyperplasia - The Effect of withdrawing dutasteride

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020752

Enrollment

250

Registered

2016-02-01

Start date

2016-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: the patients taking dutasteride orally

Exclusion criteria

Exclusion criteria: the patinets who can't fill questionnaire about benign prostatic hyperplasia

Design outcomes

Primary

Measure	Time frame
the change of prostate size and IPSS	—

Secondary

Measure	Time frame
the change of the parameter on uroflowmeter and PSA	—

Countries

Japan

Contacts

Public ContactMatsukawa Yoshihisa

Nagoya University Graduate School of Medicine Department of urology

yoshi44@med.nagoya-u.ac.jp+81-52-744-2985

Outcome results